DDR on DTC: Prilosec

Share this article:
AstraZeneca has proven repeatedly that DTC drives business. They were among the earliest innovators with their DTC launch for Prilosec more than 10 years ago. Many brands and campaigns later, we still have to admire their DTC savvy with their latest Nexium spots.

These two 30-second commercials—one of which involves a man jacking up the head of his bed and the other, a woman trying to chug a water-cooler-size jug of water—are both effective and efficient because they focus on one problem for the brand to solve. This is missing in many DTC ads that are stuffed with educational goals, product and emotional benefits, safety/side effects and savings info. It gets to the point where some viewers aren't sure what the product does or what they should do about it. Not so here. Each Nexium ad focuses on one key problem for heartburn sufferers—the pain is worse at night/when lying down. They use humor to illustrate the problem, and of course, the brand is the hero/reliever. The ads are simple and clever and the sly humor quickly focuses the viewer's attention on the problem. In this category—which is crowded with Rx, OTC and generic competitors—the ads must grab viewers' attention and deliver important info fast.

A few months ago, when AdAge ran the feature “Pharma Marketing is Embarrassing,” which lambasted DTC creative, the author was inundated with comments about how shortsighted and wrong he was. He obviously hadn't seen this effective, well-produced and charming campaign!

Deborah Dick-Rath is SVP, healthcare practice leader, at FactorTG. Contact: deborah.dick-rath@factortg.com
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...